Mail

Canada markets close in 1 hour 27 minutes

S&P/TSX
22,309.95
-65.88(-0.29%)
S&P 500
5,216.80
+2.72(+0.05%)
DOW
39,460.36
+72.60(+0.18%)
CAD/USD
0.7312
+0.0001(+0.01%)
CRUDE OIL
78.42
-0.84(-1.06%)
Bitcoin CAD
82,657.88
-2,278.36(-2.68%)

MARKETS LIVE BLOG

STOCKS MIXED AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

3.4700

+0.1000

(+2.97%)

As of 02:03PM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	48.92M
Enterprise Value	13.02M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	1.39
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	0.88
52-Week Change ³	63.59%
S&P500 52-Week Change ³	26.43%
52 Week High ³	3.8800
52 Week Low ³	1.5600
50-Day Moving Average ³	2.5672
200-Day Moving Average ³	2.0380

Share Statistics

Avg Vol (3 month) ³	1.45M
Avg Vol (10 day) ³	93.33k
Shares Outstanding ⁵	14.51M
Implied Shares Outstanding ⁶	14.73M
Float ⁸	4.93M
% Held by Insiders ¹	1.29%
% Held by Institutions ¹	76.97%
Shares Short (Apr 15, 2024) ⁴	5.66M
Short Ratio (Apr 15, 2024) ⁴	1.37
Short % of Float (Apr 15, 2024) ⁴	54.63%
Short % of Shares Outstanding (Apr 15, 2024) ⁴	39.05%
Shares Short (prior month Mar 15, 2024) ⁴	183.58k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Apr 04, 2019
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:18
Last Split Date ³	Apr 04, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-12.67%
Return on Equity (ttm)	-15.87%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-7.97M
Net Income Avi to Common (ttm)	-6M
Diluted EPS (ttm)	-0.4200
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	35.9M
Total Cash Per Share (mrq)	2.47
Total Debt (mrq)	48k
Total Debt/Equity (mrq)	0.14%
Current Ratio (mrq)	23.19
Book Value Per Share (mrq)	2.42

Cash Flow Statement

Operating Cash Flow (ttm)	-4.95M
Levered Free Cash Flow (ttm)	-3.84M